{"full_title_en": "CKD-EPI Equations for Glomerular Filtration Rate (GFR)", "instructions_en": "<p>For use in patients with stable kidney function. While the combined creatinine and cystatin C equation can add accuracy, cystatin c is not available in all laboratories and the creatinine-based equation is adequate for many clinical purposes.</p>\n<p>2021 CKD-EPI creatinine is currently recommended by the ASN and NKF for GFR reporting in the United States.</p>", "search_abbreviation_en": ["CKD", "CKD EPI", "kidney failure", "renal failure", "chronic renal failure", "CRF", "GFR", "glomerular filtration rate", "cystatin C", "cystatin", "creatinine", "cr", "scr", "egfr", "estimated gfr"], "calc_type": "calculator", "before_use": "<p>The 2021 CKD-EPI equation is now the recommended standard. This version does not include race, as do the 2009 and 2012 CKD-EPI creatinine and creatinine-cystatin C equations. <a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a> for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>With the 2021 equation, for the same creatinine value, the 2021 equation will estimate a lower GFR for Black patients and a higher GFR for non-Black patients.</p>", "cmeLastReviewed": null, "purpose_en": ["Calculation"], "specialty_en": ["Nephrology", "Pharmacy"], "slug": "ckd-epi-equations-glomerular-filtration-rate-gfr", "disease_en": ["Diabetes Mellitus", "Kidney Failure", "Renal Failure"], "cmeEndDate": null, "short_description_en": "Estimates GFR.", "short_title_en": "CKD-EPI Equations for GFR", "medium_description_en": "Estimates GFR based on serum creatinine, serum cystatin C, or both.", "input_schema": [{"optional": false, "default": null, "show_points": false, "conditionality": "", "name": "calc", "tips_en": "", "label_en": "<p>Equation</p>", "type": "radio", "options": [{"label": "2021 CKD-EPI Creatinine", "value": 3}, {"label": "2021 CKD-EPI Creatinine-Cystatin C", "value": 4}, {"label": "2009 CKD-EPI Creatinine", "value": 0}, {"label": "2012 CKD-EPI Cystatin C", "value": 1}, {"label": "2012 CKD-EPI Creatinine\u2013Cystatin C", "value": 2}]}, {"optional": false, "default": null, "show_points": false, "conditionality": "", "name": "gender", "tips_en": "", "label_en": "<p>Sex</p>", "type": "toggle", "options": [{"label": "Female", "value": 0}, {"label": "Male", "value": 1}]}, {"optional": false, "default": null, "unit": "age", "conditionality": "", "name": "age", "tips_en": "", "label_en": "<p>Age</p>", "type": "textbox", "unit_info": {"name": "Age", "conversion": 1, "error_min": 0.001, "error_max": 120, "warn_min": 0.1, "warn_max": 100, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "years", "units_us": "years"}}, {"optional": false, "default": null, "unit": "cr", "conditionality": "calc == 0 || calc == 2 || calc == 3 || calc == 4", "name": "scr", "tips_en": "", "label_en": "<p>Serum creatinine</p>", "type": "textbox", "unit_info": {"name": "Creatinine", "conversion": 88.4, "error_min": 0.01, "error_max": 40, "warn_min": 0, "warn_max": 10, "normal_max_si": 115, "normal_min_si": 62, "normal_min_us": 0.7, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.3}}, {"optional": false, "default": null, "unit": "serum_cystatinc", "conditionality": "calc == 1 || calc == 2 || calc == 4", "name": "scys", "tips_en": "", "label_en": "<p>Serum cystatin C</p>", "type": "textbox", "unit_info": {"name": "Serum cystatin C", "conversion": 1, "error_min": 0, "error_max": 30, "warn_min": 0, "warn_max": 10, "normal_max_si": 0.98, "normal_min_si": 0.51, "normal_min_us": 0.51, "units_si": "mg/L", "units_us": "mg/L", "normal_max_us": 0.98}}, {"optional": true, "default": null, "show_points": false, "conditionality": "calc == 0 || calc == 2", "name": "race", "tips_en": "Race may/may not provide better estimates of GFR; optional", "label_en": "<p>Race</p>", "type": "radio", "options": [{"label": "Black", "value": 1}, {"label": "Non-black", "value": 2}]}], "chief_complaint_en": ["AMS", "Extremity Edema", "Weakness"], "content": {"reviewer": {"expert_name": []}, "related_resources": {"videos": [], "sdm_tool": [], "teaching": [], "interests": [], "guidelines": [], "mdcalc_rating": [], "partner_contact": []}, "how_to_use": {"use_case_en": "<ul>\n<li>Patients with chronic kidney disease (not acute), to measure kidney function.</li>\n<li>CKD-EPI Creatinine is more commonly available.</li>\n<li>2021 CKD-EPI creatinine-cystatin is recommended as a confirmatory test in patients at extremes of body type (e.g. obese patients, high or low muscle mass).</li>\n</ul>", "pearls_pitfalls_en": "<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<div>In 2021 new equations were created to remove the race components from the prior CKD-Epi equations and should be the new standard equations; we continue to offer the prior equations for comparison/trending.</div>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<div>Creatinine-based estimates of kidney function by glomerular filtration rate (GFR) are less accurate in certain populations including patients with diabetes (before progression to overt nephropathy with diminished GFR), pregnant women, those with unusual body mass (e.g. obese, severely malnourished, amputees, paraplegics, etc).</div>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<div>Not for use in patients on dialysis.</div>\n</li>\n</ul>", "why_use_en": "<p>The CKD-EPI equation performs superiorly to the <calculator id=\"76\">MDRD Equation</calculator> in patients with normal or mildly reduced estimated GFR (eGFR), and just as well in patients with an eGFR of &lt;60 mL/min/m<sup>2</sup>. It is used most widely by nephrologists and understood to be the most accurate means of non-invasively assessing GFR in the United States.</p>"}, "next_steps": {"advice_en": "<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Patients with decreased GFR are at higher risk of progressive kidney disease. Management of contributing risk factors, such as diabetes and hypertension, is critical to slowing progression. Investigation of the underlying cause of decreased GFR is warranted if not clear from the history.&nbsp;</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Medications should be dose-adjusted for the most recent available eGFR (in this setting, eGFR and creatinine clearance may be used interchangeably, though they are physiologically different terms). Cutoffs for many medications are &lt;60, &lt;45, and &lt;30 mL/min/m<sup>2</sup>, as well as adjustments for advanced kidney disease and dialysis patients.</p>\n</li>\n</ul>", "management_en": "<p>Patients should be classified into CKD stage by both eGFR and albuminuria status. Patients with decreased GFR, increased urinary albumin excretion or both, are at high risk of progressive CKD and should be referred to nephrology for further management.</p>\n<p><span id=\"docs-internal-guid-24ec0e1a-7fff-2d3a-e165-68904145ba7e\"><span style=\"font-size: 8.5pt; font-family: Verdana; color: #0000ff; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"><span style=\"border: none; display: inline-block; overflow: hidden; width: 449px; height: 348px;\"><img src=\"https://lh4.googleusercontent.com/jESIiorayF2HrbN6w8uHPfGuePhVo617uturDL5LfW6CMhl8XmmVzIF6XCyWgnt1pDv3qhZk5u5yIqKW9if99EpbQnJ-xV8P9sw4rAbMkhhhq6Hie6iKUanqUQS6qHD4_fPLbg4P\" width=\"449\" height=\"348\" style=\"margin-left: 0px; margin-top: 0px;\"><br>From <a href=\"https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf\" target=\"_blank\" rel=\"noopener\">KDIGO 2012 Clinical Practice Guideline</a>.</span></span></span></p>\n<p><span id=\"docs-internal-guid-b45049c5-7fff-6b30-532d-7e12d13567c0\">From <a href=\"https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf\" target=\"_blank\" rel=\"noopener\">KDIGO 2012 Clinical Practice Guideline</a>.</span></p>", "critical_actions_en": ""}, "about": {"formula_en": "<p><strong>2021&nbsp; CKD-EPI Creatinine&nbsp;</strong>= 142 x (Scr/A)<sup>B</sup> x 0.9938<sup><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">age </span></sup><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">x (1.012 if female), where A and B are the following:<strong></strong></span></p>\n<p><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\"></span></p>\n<table style=\"width: 58.932%; height: 380px;\">\n<tbody>\n<tr style=\"height: 54px;\">\n<td colspan=\"2\" style=\"width: 50.1425%; height: 54px;\">\n<p><strong>Female</strong></p>\n</td>\n<td colspan=\"2\" style=\"width: 49.8575%; height: 54px;\">\n<p><strong>Male</strong></p>\n</td>\n</tr>\n<tr style=\"height: 158px;\">\n<td style=\"width: 22.2222%; height: 158px;\">\n<p><strong>Scr &le;0.7</strong></p>\n</td>\n<td style=\"width: 27.9202%; height: 158px;\">\n<p><em>A</em> = 0.7</p>\n<p><em>B </em>= -0.241</p>\n</td>\n<td style=\"width: 23.3618%; height: 158px;\">\n<p><strong>Scr &le;0.9</strong></p>\n</td>\n<td style=\"width: 26.4957%; height: 158px;\">\n<p><em>A</em>&nbsp;= 0.9</p>\n<p><em>B</em> = -0.302</p>\n</td>\n</tr>\n<tr style=\"height: 168px;\">\n<td style=\"width: 22.2222%; height: 168px;\">\n<p><strong>Scr &gt;0.7</strong></p>\n</td>\n<td style=\"width: 27.9202%; height: 168px;\">\n<p>A = 0.7</p>\n<p>B = -1.2</p>\n</td>\n<td style=\"width: 23.3618%; height: 168px;\">\n<p><strong>Scr &gt;0.9</strong></p>\n</td>\n<td style=\"width: 26.4957%; height: 168px;\">\n<p><em></em></p>\n<p><em>A</em>&nbsp;= 0.9</p>\n<p><em>B</em>&nbsp;= -1.2</p>\n<p></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>2021&nbsp; CKD-EPI Creatinine-</strong><strong style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Cystatin C&nbsp;</strong>= 135 x (Scr/A)<sup>B</sup> x (Scys/C)<sup>D</sup> x 0.9961<sup>age</sup> x (0.963 if female), where A, B, C, and D are the following:<strong></strong></p>\n<p>Female:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Scr &le;0.7</strong></p>\n</td>\n<td>\n<p><strong>Scr &gt;0.7</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &le;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 0.7</p>\n<p><em>B</em> = -0.219</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.323</p>\n</td>\n<td>\n<p><em>A</em> = 0.7</p>\n<p><em>B</em> = -0.544</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.323</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &gt;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 0.7</p>\n<p><em>B</em> = -0.219</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.778</p>\n</td>\n<td>\n<p><em></em></p>\n<p><em>A</em> = 0.7</p>\n<p><em>B</em> = -0.544</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.778</p>\n<p></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Male:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Scr &le;0.9</strong></p>\n</td>\n<td>\n<p><strong>Scr &gt;0.9</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &le;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 0.9</p>\n<p><em>B</em> = -0.144</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.323</p>\n</td>\n<td>\n<p><em>A</em> = 0.9</p>\n<p><em>B</em> = -0.544</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.323</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &gt;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 0.9</p>\n<p><em>B</em> = -0.144</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.778</p>\n</td>\n<td>\n<p><em></em></p>\n<p><em>A</em> = 0.9</p>\n<p><em>B</em> = -0.544</p>\n<p><em>C</em> = 0.8</p>\n<p><em>D</em> = -0.778</p>\n<p></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>2009&nbsp; <strong>CKD-EPI Creatinine </strong>= <em>A</em> &times; (Scr/<em>B</em>)<sup><em>C</em></sup> &times; 0.993<sup>age</sup> &times; (1.159 if black*), where <em>A,</em> <em>B</em>, and <em>C</em> are the following:</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Female</strong></p>\n</td>\n<td colspan=\"2\">\n<p><strong>Male</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scr &le;0.7</strong></p>\n</td>\n<td>\n<p><em>A</em> = 144</p>\n<p><em>B</em> = 0.7</p>\n<p><em>C</em> = -0.329</p>\n</td>\n<td>\n<p><strong>Scr &le;0.9</strong></p>\n</td>\n<td>\n<p><em>A</em> = 141</p>\n<p><em>B</em> = 0.9</p>\n<p><em>C</em> = -0.411</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scr &gt;0.7</strong></p>\n</td>\n<td>\n<p><em>A</em> = 144</p>\n<p><em>B</em> = 0.7</p>\n<p><em>C</em> = -1.209</p>\n</td>\n<td>\n<p><strong>Scr &gt;0.9</strong></p>\n</td>\n<td>\n<p><em>A</em> = 141</p>\n<p><em>B</em> = 0.9</p>\n<p><em>C</em> = -1.209</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>2012 CKD-EPI Cystatin C </strong>= 133 &times; (Scys/0.8)<sup><em>A</em></sup> &times; 0.996<sup>age</sup> &times; <em>B,</em> where <em>A </em>and <em>B </em>are the following:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Female</strong></p>\n</td>\n<td>\n<p><strong>Male</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &le;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = -0.499</p>\n<p><em>B</em> = 0.932</p>\n</td>\n<td>\n<p><em>A</em> = -0.499</p>\n<p><em>B</em> = 1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &gt;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = -0.499</p>\n<p><em>B</em> = 0.932</p>\n</td>\n<td>\n<p><em>A</em> = -0.499</p>\n<p><em>B</em> = 1</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>2012 CKD-EPI Creatinine&ndash;Cystatin C</strong> = <em>A</em> &times; Scr/<sup>B</sup><sup><em>C</em></sup> &times; (Scys/0.8)<sup><em>D</em></sup> &times; 0.995<sup>age</sup> &times; (1.08 if black), where <em>A, B, C, </em>and <em>D</em> are the following:<strong><br></strong></p>\n<p><strong>Female:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Scr &le;0.7</strong></p>\n</td>\n<td>\n<p><strong>Scr &gt;0.7</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &le;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 130</p>\n<p><em>B</em> = 0.7</p>\n<p><em>C</em> = -0.248</p>\n<p><em>D</em> = -0.375</p>\n</td>\n<td>\n<p><em>A</em> = 130</p>\n<p><em>B</em> = 0.7</p>\n<p><em>C</em> = -0.601</p>\n<p><em>D</em> = -0.375</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &gt;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 130</p>\n<p><em>B</em> = 0.7</p>\n<p><em>C</em> = -0.248</p>\n<p><em>D</em> = -0.711</p>\n</td>\n<td>\n<p><em>A</em> = 130</p>\n<p><em>B</em> = 0.7</p>\n<p><em>C</em> = -0.601</p>\n<p><em>D</em> = -0.711</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Male:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Scr &le;0.9</strong></p>\n</td>\n<td>\n<p><strong>Scr &gt;0.9</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &le;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 135</p>\n<p><em>B</em> = 0.9</p>\n<p><em>C</em> = -0.207</p>\n<p><em>D</em> = -0.375</p>\n</td>\n<td>\n<p><em>A</em> = 135</p>\n<p><em>B</em> = 0.9</p>\n<p><em>C</em> = -0.601</p>\n<p><em>D</em> = -0.375</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scys &gt;0.8</strong></p>\n</td>\n<td>\n<p><em>A</em> = 135</p>\n<p><em>B</em> = 0.9</p>\n<p><em>C</em> = -0.207</p>\n<p><em>D</em> = -0.711</p>\n</td>\n<td>\n<p><em>A</em> = 135</p>\n<p><em>B</em> = 0.9</p>\n<p><em>C</em> = -0.601</p>\n<p><em>D</em> = -0.711</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Scr, serum creatinine. Scys, serum cystatin C.</p>\n<p>*Race may/may not provide better estimates of GFR; optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing race and bias on MDCalc.</p>", "more_info_en": "<p><span id=\"docs-internal-guid-f27f91a7-7fff-b254-fc3a-1e697408ec94\"><span style=\"font-size: 8.5pt; font-family: Verdana; color: #0000ff; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"><span style=\"border: none; display: inline-block; overflow: hidden; width: 449px; height: 348px;\"><img src=\"https://lh4.googleusercontent.com/jESIiorayF2HrbN6w8uHPfGuePhVo617uturDL5LfW6CMhl8XmmVzIF6XCyWgnt1pDv3qhZk5u5yIqKW9if99EpbQnJ-xV8P9sw4rAbMkhhhq6Hie6iKUanqUQS6qHD4_fPLbg4P\" width=\"449\" height=\"348\" style=\"margin-left: 0px; margin-top: 0px;\"></span></span></span></p>\n<p>From&nbsp;<a href=\"https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf\" target=\"_blank\" rel=\"noopener\">KDIGO 2012 Clinical Practice Guideline</a>.</p>", "evidence_based_medicine_en": "<p>The CKD-EPI (creatinine) was developed by <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19414839\" target=\"_blank\" rel=\"noopener\">Levey et al in 2009</a>, who measured GFR of 8,254 participants using clearance of iothalamate (the most recent recommended gold standard). Linear regression was used to estimate the logarithm of measured GFR from standardized creatinine levels, sex, race, and age.</p>\n<p>The equation was validated by <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22762315\" target=\"_blank\" rel=\"noopener\">Inker et al (2012)</a> and found to be more accurate than the <calculator id=\"76\">MDRD Equation</calculator>&nbsp;(percentage of estimated GFR within 30% of measured GFR was 84.1% vs. 80.6%). The sensitivity and specificity of estimated GFR &lt;60 mL/min/1.73 m<sup>2</sup> were 91% and 87%, respectively, using the CKD-EPI equation and 95% and 82%, respectively, using the MDRD Equation.</p>\n<p>Debate has arisen regarding the use of the adjustment coefficient for black patients. Because of this, <a href=\"https://pubmed.ncbi.nlm.nih.gov/34554658/\" target=\"_blank\" rel=\"noopener\">Inker et al (2021)</a> updated the CKD-EPI formulae to redevelop the equation so that the race component was removed from the equation.</p>", "references_list": {"Validation": [], "Outcomes": [], "Validations": [], "Original/Primary Reference": [{"text": "Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/19414839 "}, {"text": "Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-9.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/22762315  "}, {"text": "Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin c-based equations to estimate gfr without race. N Engl J Med. Published online September 23, 2021.", "href": "https://pubmed.ncbi.nlm.nih.gov/34554658/"}], "Other References": [{"text": "Diabetes in ckd \u2013 kdigo.", "href": "https://kdigo.org/guidelines/diabetes-ckd/"}], "Clinical Practice Guidelines": [], "Manufacturer Website": []}}, "creator": [{"qa_en": "", "approved": true, "name": "Dr. Andrew S. Levey", "creator_info": {"about_en": "<p>Andrew S. Levey, MD, is the chief of the nephrology division at Tufts Medical Center and the Dr. Gerald J. and Dorothy R. Friedman Professor at Tufts University School of Medicine. His clinical interests include chronic kidney disease (CKD), diabetic kidney disease, and systemic lupus erythematosus. Dr. Levey\u2019s research focuses on laboratory measures to estimate kidney function, new therapies, and the development of clinical practice guidelines for CKD.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-andrew-levey.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Levey+AS%5BAuthor%5D"}}, {"qa_en": "", "approved": true, "name": "Dr. Lesley A. Inker", "creator_info": {"about_en": "<p><span>Lesley A. Inker, MD, MS, is an associate professor at Tufts University School of Medicine, an attending physician in the William B. Schwartz, MD Division of Nephrology at Tufts Medical Center, and medical director of the Kidney And Blood Pressure Center at Tufts Medical Center in Massachusetts. Dr. Inker's primary research interests are in GFR measurement and estimation, alternative endpoints for clinical trials of kidney disease progression, and epidemiology and outcomes related to CKD.</span></p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-lesley-a-inker.jpg", "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Inker+LA%5BAuthor%5D"}}, {"qa_en": "", "approved": true, "name": "The CKD Epidemiology Collaboration (CKD-EPI)", "creator_info": {"about_en": "<p><span>The&nbsp;</span><span class=\"il\">CKD</span><span>&nbsp;</span><span class=\"il\">Epidemiology</span><span>&nbsp;</span><span class=\"il\">Collaboration</span><span>&nbsp;(</span><span class=\"il\">CKD</span><span>-</span><span class=\"il\">EPI</span><span>) is a research group&nbsp; with interests in measurement&nbsp; and estimation of GFR (</span><span class=\"il\">CKD</span><span>-</span><span class=\"il\">EPI</span><span>&nbsp;GFR) and evaluation of surrogate endpoints for clinical trials in&nbsp;</span><span class=\"il\">CKD</span><span>&nbsp;(</span><span class=\"il\">CKD</span><span>-</span><span class=\"il\">EPI</span><span>&nbsp;CT).&nbsp;</span><span class=\"il\">CKD</span><span>-</span><span class=\"il\">EPI</span><span>&nbsp;was founded by Dr. Andrew S. Levey who served as Director from&nbsp; 2004 to 2018 and continues to serve as co-director. Dr. Lesley A. Inker has been the Director of the Data Coordinating Center (DCC) from 2004 and Co-Director since 2018.</span></p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/ckd-epi.png"}}], "contributor": {"expert_name": [{"description": "", "firstName": "Omar", "img": "", "lastName": "Aziz", "name": "Omar Aziz, MD", "target": "", "signedCOI": true, "hasDisclosure": []}]}, "reviewers": []}, "system_en": ["Renal", "Urinary"], "cmeReleaseDate": null, "dosing": false, "seo": {"meta_description_en": "The CKD-EPI Creatinine Equation for Glomerular Filtration Rate (GFR) estimates GFR based on serum creatinine.", "keywords_en": "CKD-EPI, CKD EPI, EPI equation, renal failure, chronic renal failure, chronic kidney disease, GFR, glomerular filtration rate, cystatin C, cystatin, creatinine, cr, scr"}, "cmeVersion": null, "md5": "20a487e4066ed41803155d912cd2b402", "favorite_id": 3939, "related_calcs": [{"calcId": 76, "short_title_en": "MDRD GFR Equation", "slug": "mdrd-gfr-equation"}, {"calcId": 10045, "short_title_en": "Kidney Failure Risk Calculator", "slug": "kidney-failure-risk-calculator"}, {"calcId": 10191, "short_title_en": "Kinetic Estimated Glomerular Filtration Rate (keGFR)", "slug": "kinetic-estimated-glomerular-filtration-rate-kegfr"}]}